Apotea AB (APOTEA.ST) Stock Analysis & Winston Score
Apotea is Sweden's largest online pharmacy. It sells prescription medicines, over-the-counter drugs, vitamins, and health and beauty products directly to consumers through its website and app. The company operates a highly automated warehouse near Stockholm that lets it ship orders quickly across Sweden. Apotea makes money by selling products at a markup, much like a traditional retailer but without expensive physical stores. This online-only model keeps costs low and helps the company offer competitive prices, which has built strong brand recognition and customer loyalty in Sweden. Its large customer base and efficient logistics give it a scale advantage over smaller competitors. Key growth opportunities include expanding its product range and potentially entering new Nordic markets, though increasing competition from both online and brick-and-mortar pharmacies remains a notable risk.
Winston Score: 50/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Good (16/30)
- Growth: Mixed (6/20)
- Cash Flow: Good (6/10)
- Stability: Good (5/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: 74.90 SEK
Market Cap: 7.8B SEK
Sector: Consumer Cyclical
Industry: Specialty Retail
Exchange: Stockholm Stock Exchange


